placeholder image
S. E. Nissen All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: the EXAMINE trial. 
    Diabetes, Obesity & Metabolism. 2017
  • Angiotensin-converting enzyme inhibitor use and major cardiovascular outcomes in type 2 diabetes mellitus treated with the dipeptidyl peptidase 4 inhibitor alogliptin. 
    Hypertension (Dallas, Tex.. 2016
  • Cardiovascular mortality in patients with type 2 diabetes and recent acute coronary syndromes from the EXAMINE Trial. 
    Diabetes care. 2016
  • Liraglutide and cardiovascular outcomes in type 2 diabetes. 
    New England Journal of Medicine. 2016
  • Alogliptin after acute coronary syndrome in patients with type 2 diabetes. 
    New England Journal of Medicine. 2013
  • Design of the liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial. 
    American Heart Journal. 2013
  • EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome (EXAMINE): a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndrome. 
    American Heart Journal. 2011
    • Abstract
  • Mortality findings from the EXAMINE Trial [abstract]. 
    Diabetes. 2016
  • Major cardiovascular outcomes in the EXAMINE trial according to ACE inhibitor use [abstract]. 
    Diabetes. 2015
    • Contact
    full name
  • S. E. Nissen
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration